RELIght: A two‐year REal‐LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response
Maria Kallieri, Εleftherios Ζervas, Evangelia Fouka, Κonstantinos Porpodis, Marija Hadji Mitrova, Eleni Tzortzaki, Μichael Μakris, Maria Ntakoula, Andriana Ι. Papaioannou, Panagiotis Lyberopoulos, Katerina Dimakou, Sofia Koukidou, Sevasti Ampelioti, Anastasia Papaporfyriou, Κonstantinos Κatsoulis, Maria Kipourou, Νikoletta Ρovina, Κατερίνα Αντωνίου, Stylianos Vittorakis, Petros Bakakos, Paschalis Steiropoulos, Katerina Markopoulou, Panteleimon Avarlis, Ιlias Papanikolaou, Μiltiadis Μarkatos, Εleni Gaki, Κonstantinos Samitas, Konstantinos Glynos, Spyros A. Papiris, Despoina Papakosta, Νikolaos Tzanakis, Mina Gaga, Κonstantinos Κostikas, Stelios Loukides
Abstract
Appendix S1 Table S1-S4 Fig S1-S4 Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.